A phase-II study of neoadjuvant chemotherapy in T3-4N0-XM0 transitional cell carcinoma of the bladder: a preliminary analysis.
Splinter
T A
TA
University Hospital Dijkzigt, Rotterdam, The Netherlands.
Schröder
F H
FH
Denis
L
L
Newling
D
D
Jacqmin
D
D
Hall
R R
RR
de Pauw
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D002945:Cisplatin; D008727:Methotrexate